Abstract
Huseni etal. report that IL-6-STAT3 signaling negatively impacts the anti-tumor function of cytotoxic Tcells. Targeting IL-6 signaling may enhance tumor responses to immune checkpoint blockade therapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
